Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Lunaphore Technologies

Explore full profile

Builds tumor analysis platforms performing immunohistochemistry using microfluidic technology

Tolochenaz, SwitzerlandFounded 2014Biotech & Life Sciences
Valuation $100–250M Last recorded · 2023
Headcount <100 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Lunaphore Technologies and the history behind them.

About Lunaphore Technologies

Lunaphore is a startup operating in the biotechnology sector, specifically focusing on spatial biology. The company's primary goal is to make spatial biology accessible to every lab, thereby accelerating research in this field. Spatial biology is a scientific discipline that studies the spatial distribution and organization of biological molecules within cells and tissues. Lunaphore's technology enables researchers to integrate spatial biology into their work with ease and precision.

The company's main clients are research laboratories that require advanced technology to conduct their studies. Lunaphore's business model is based on providing these labs with a scalable, fast, and end-to-end precision technology. This technology allows labs to choose their preferred antibodies without any secretive formulas, making it a flexible and intuitive solution. The company's technology has been used in various research studies, including a study on COVID-19 placentitis, where it provided a spatial, high-dimensional overview of immune infiltrate.

Lunaphore generates revenue by selling its technology to research labs. The company's technology is designed to be easily integrated into existing lab setups, making it a cost-effective solution for labs looking to incorporate spatial biology into their research. The company also provides ongoing support to labs, ensuring they can effectively use the technology.

In summary, Lunaphore is a biotech startup that provides advanced spatial biology technology to research labs. The company's technology is scalable, fast, and flexible, making it a valuable tool for labs conducting complex biological research.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2014
Headquarters
Tolochenaz, Switzerland
Employees
107
Open positions
None listed
Dealroom signal
63.3/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotech & Life Sciences, Testing, Analytics, Biotechnology, Oncology, Health Diagnostics, Spinout, Techbio, Woman Founder, Techbio Drug Discovery, Horizon Europe
Business model
Manufacturing

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONOther financing Jun 2023 — — Bio-Techne ↗
DEBTDebt Mar 2023 $11M — Norgine Ventures ↗
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

Lunaphore Technologies website traffic

Latest recorded traffic for Lunaphore Technologies is 22K monthly website visits, up 100% over the last three months. Lunaphore Technologies's team declined 20.1% over the past year.

Latest monthly visits22K 3-month web change+100% 1-year team growth-20.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

14 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Fondation FIT

Series A5 investors entered at this stage

  • Redalpine
  • Polytech Ventures
  • Zühlke Ventures
  • Alpana Ventures
  • OCCIDENT

Series B and later5 investors entered at this stage

  • ZKB - Zürcher Kantonalbank
  • Phc
  • Swiss Entrepreneurs Foundation
  • Norgine Ventures
  • EGS Beteiligungen

Other known investors3 additional known investors

  • Bio-Techne
  • EPFL Swiss Federal Polytechnic School of Lausanne
  • Swissnex
Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
8 countries with
team presence
🇨🇭 Switzerland76.8%
🇺🇸 United States11.2%
🇩🇪 Germany4.8%
🇬🇧 United Kingdom2.4%
🇫🇷 France1.6%
Top 5 of 8 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Lunaphore Technologies on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Lunaphore Technologies’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.